Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Methylphenidate Extended-Release Dosing Guidelines

Introduction to Dosing

  • The American Academy of Pediatrics recommends that methylphenidate ER is not typically used as first-line treatment for preschool-aged children, and behavioral interventions should be tried first before considering medication 3, 4
  • The recommended starting dose of methylphenidate extended-release (ER) is 18 mg once daily for children and adolescents, according to the American Academy of Child and Adolescent Psychiatry 1, 2

Dosing by Age Group

  • For school-age children (6-12 years), the starting dose is 18 mg once daily in the morning, which can be titrated up based on response and tolerability, with a maximum daily dose of 60-72 mg depending on formulation, as recommended by the American Academy of Pediatrics 1, 2
  • For adolescents (12-18 years), the starting dose is 18 mg once daily in the morning, with a maximum daily dose of 60-72 mg depending on formulation, and special consideration should be given to medication coverage for symptom control while driving due to increased risk of motor vehicle accidents, as recommended by the American Academy of Pediatrics 1, 2, 4

Titration and Monitoring

  • The American Academy of Child and Adolescent Psychiatry recommends beginning with the lowest available dose and titrating upward based on clinical response 1
  • Monitoring for common side effects, particularly insomnia, irritability, and increased heart rate or blood pressure, is recommended by the National Comprehensive Cancer Network 5

Contraindications and Cautions

  • The National Comprehensive Cancer Network recommends avoiding methylphenidate in patients with uncontrolled hypertension, underlying coronary artery disease, or tachyarrhythmias 5
  • The American Academy of Pediatrics recommends using methylphenidate with caution in patients with a history of substance use disorder, and monitoring for signs of diversion or misuse, particularly in adolescents 4